| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Anacardic acid |
漆树酸 |
16611-84-0 |
详细
|
| BEZ235 |
NVP-BEZ235 |
915019-65-7 |
详细
|
| API-1 |
4-Amino-5,6,7,8-tetrahydro-5-oxo-8-(β-D-ribofuranosyl)pyrido[2,3-d]pyrimidine-6-carboxamide |
36707-00-3 |
详细
|
| PI-3065 |
PI-3065 |
955977-50-1 |
详细
|
| Serabelisib |
[6-(2-氨基-5-苯并恶唑基)咪唑并[1,2-A]吡啶-3-基]-4-吗啉基甲酮 |
1268454-23-4 |
详细
|
| Rapamycin |
雷帕霉素 |
53123-88-9 |
详细
|
| Presatovir |
GS-5806 |
1353625-73-6 |
详细
|
| Lifirafenib |
LIFIRAFENIB |
1446090-79-4 |
详细
|
| CU-T12-9 |
CU-T12-9 |
1821387-73-8 |
详细
|
| YKL-05-099 |
化合物YKL-05-099 |
1936529-65-5 |
详细
|
| DDD107498 |
1469439-69-7 |
1469439-69-7 |
详细
|
| Givinostat (ITF2357) |
N-[4-[(羟基氨基)羰基]苯基]氨基甲酸 [6-[(二乙基氨基)甲基]-2-萘基]甲酯盐酸盐水合物 |
732302-99-7 |
详细
|
| Isoxazole 9 (ISX-9) |
ISX 9 |
832115-62-5 |
详细
|
| AZD5363 |
4-氨基-N-[(1S)-1-(4-氯苯基)-3-羟基丙基]-1-(7H-吡咯并[2,3-D]嘧啶-4-基)-4-哌啶甲酰胺 |
1143532-39-1 |
详细
|
| GSK-J4 Hydrochloride |
GSK-J4 盐酸盐 |
1797983-09-5 |
详细
|
| Liproxstatin-1 |
利普司他丁-1 |
950455-15-9 |
详细
|
| RK-33 |
RK-33 |
1070773-09-9 |
详细
|
| PF-9366 |
PF-9366 |
72882-78-1 |
详细
|
| CM-272 |
化合物CM-272 |
1846570-31-7 |
详细
|
| Veliparib |
维利帕尼 |
912444-00-9 |
详细
|
| AZ 628 |
AZ 628 |
878739-06-1 |
详细
|
| MRT67307 |
N-[3-[[5-环丙基-2-[[3-(4-吗啉基甲基)苯基]氨基]-4-嘧啶基]氨基]丙基]环丁烷甲酰胺 |
1190378-57-4 |
详细
|
| UNC0638 |
UNC0638 |
1255580-76-7 |
详细
|
| AR7 |
CS-2649 |
80306-38-3 |
详细
|
| HTH-01-015 |
HTH-01-015 |
1613724-42-7 |
详细
|
| BAM 15 |
CS-2890 |
210302-17-3 |
详细
|
| 1,3-Benzenediol, 4-[1-(2-propenyl)-7-(trifluoromethyl)-1H-indazol-3-yl]- |
1,3-Benzenediol, 4-[1-(2-propenyl)-7-(trifluoromethyl)-1H-indazol-3-yl]- |
669764-18-5 |
详细
|
| Pyrimorph |
丁吡吗啉 |
868390-90-3 |
详细
|
| R-10015 |
METHYL 2-(1-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERIDIN-4-YL)-1H-BENZO[D]IMIDAZOLE-6-CARBOXYLATE |
2097938-51-5 |
详细
|
| TK216 |
TK216 |
1903783-48-1 |
详细
|
| VPC-80051 |
1H-Indazole-3-carboxamide, N-[1-(3,4-difluorophenyl)ethyl]- |
877969-69-2 |
详细
|
| Losmapimod |
Losmapimod (GW856553X) |
585543-15-3 |
详细
|
| MM-102 |
MM-102 |
1417329-24-8 |
详细
|
| 1-(2,4-Dichlorophenyl)-N-1-piperidinyl-4-[[(1-pyrrolidinylsulfonyl)amino]methyl]-5-[5-[2-[4-(trifluoromethyl)phenyl]ethynyl]-2-thienyl]-1H-pyrazole-3-carboxamide |
1-(2,4-二氯苯基)-N-1-哌啶基-4-[[(1-吡咯烷基磺酰基)氨基]甲基]-5-[5-[2-[4-(三氟甲基)苯基]乙炔基]-2-噻吩基]-1H-吡唑-3-甲酰胺 |
1429239-98-4 |
详细
|
| Aldose reductase-IN-1 |
AT-001 |
1355612-71-3 |
详细
|
| MK2-IN-3 |
2-[2-(3-quinolyl)-4-pyridyl]-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one |
724711-21-1 |
详细
|
| PythiDC |
化合物PYTHIDC |
1821370-71-1 |
详细
|
| Mizagliflozin (KWA 0711) |
Mizagliflozin |
666843-10-3 |
详细
|
| PRE-084 hydrochloride |
1-苯基环己烷羧酸 2-(4-吗啉基)乙基酯盐酸盐 |
75136-54-8 |
详细
|
| AnsamitocinP-3 |
安丝菌素 P 3 |
66584-72-3 |
详细
|
| UPF 1069 |
5-(2-氧代-2-苯基乙氧基)-1(2H)-异喹啉酮 |
1048371-03-4 |
详细
|
| A66 |
A66 |
1166227-08-2 |
详细
|
| HDAC6 inhibitor |
HDAC6 Inhibitor |
1045792-66-2 |
详细
|
| NIBR-0213 |
NIBR 0213 |
1233332-14-3 |
详细
|
| Vactosertib (TEW-7197) |
EW-7197 |
1352608-82-2 |
详细
|
| MBQ-167 |
MBQ 167;MBQ167 |
2097938-73-1 |
详细
|
| WYC-209 |
4,5-二(羟甲基)-2-苯基-1H-咪唑 |
2131803-90-0 |
详细
|
| FMK |
FMK |
821794-92-7 |
详细
|
| KU-60019 |
KU-60019 |
925701-49-1 |
详细
|
| VE-821 |
3-氨基-6-[4-(甲基磺酰基)苯基]-N-苯基-2-吡嗪甲酰胺 |
1232410-49-9 |
详细
|
| DCC-2036 |
N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-基]-N'-[2-氟-4-[(2-(甲基氨基甲酰基)吡啶-4-基)氧]苯基]脲 |
1020172-07-9 |
详细
|
| A-674563 |
A-674563 |
552325-73-2 |
详细
|
| BGT226 (NVP-BGT226) maleate |
NVP-BGT226 |
1245537-68-1 |
详细
|
| BYL719 |
阿培利司 |
1217486-61-7 |
详细
|
| GSK2636771 |
GSK2636771 |
1372540-25-4 |
详细
|
| GDC-0068 |
帕他色替 |
1001264-89-6 |
详细
|
| HS-173 |
HS-173 |
1276110-06-5 |
详细
|
| Elacestrant dihydrochloride |
RAD-1901 |
1349723-93-8 |
详细
|
| VPS34 inhibitor 1 (Compound 19) |
VPS34 |
1383716-46-8 |
详细
|
| PF-06726304 |
PF-06726304 |
1616287-82-1 |
详细
|
| RY785 |
化合物RY785 |
689297-68-5 |
详细
|
| BI-1347 |
BI-1347 |
2163056-91-3 |
详细
|
| RU-301 |
RU-301 |
1110873-99-8 |
详细
|
| Tm2-115 |
TM2-115 |
1197196-47-6 |
详细
|
| Nilotinib (AMN-107) |
尼罗替尼 |
641571-10-0 |
详细
|
| VX-150 |
N-[1,2-二氢-2-氧代-1-[(膦酰氧基)甲基]-4-吡啶基]-2-(4-氟-2-甲基苯氧基)-4-(三氟甲基)苯甲酰胺 |
1793080-72-4 |
详细
|
| CU-CPT-8m |
CPD1578 |
125079-83-6 |
详细
|
| Bosutinib (SKI-606) |
伯舒替尼 |
380843-75-4 |
详细
|
| BMPsignalingagonistsb4 |
SB 4 |
100874-08-6 |
详细
|
| UT-34 |
UT-34 |
2168525-92-4 |
详细
|
| DTHIB |
Urea, N-(4-chloro-3-nitrophenyl)-N'-(4-fluorophenyl)- |
897326-30-6 |
详细
|
| Bardoxolone |
2-氰基-3,12-二氧代齐墩果-1,9-二烯-28-酸 |
218600-44-3 |
详细
|
| PS 48 |
(Z)-5-(4-氯苯基)-3-苯基戊-2-烯酸 |
1180676-32-7 |
详细
|
| XL765 |
XL765 |
1349796-36-6 |
详细
|
| GSK-J1 |
N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸 |
1373422-53-7 |
详细
|
| IPI-3063 |
化合物IPI-3063 |
1425043-73-7 |
详细
|
| SJ000291942 |
SJ000291942 |
425613-09-8 |
详细
|
| NI 42 |
NI-42 |
1884640-99-6 |
详细
|
| Go 6983 |
3-[1-[3-(二甲基氨基)丙基]-5-甲氧基-1H-吲哚-3-基]-4-(1H-吲哚-3-基)-1H-吡咯-2,5-二酮 |
133053-19-7 |
详细
|
| Sirtinol |
2-[[(2-羟基-1-萘基)亚甲基]氨基]-N-(1-苯基乙基)苯甲酰胺 |
410536-97-9 |
详细
|
| MK-4827 (Niraparib) |
尼拉帕尼 |
1038915-60-4 |
详细
|
| TCS JNK 6o |
JNK INHIBITOR VIII (TCS JNK 6O) |
894804-07-0 |
详细
|
| IRAK inhibitor 1 |
环巴胺抑制剂 1 |
1042224-63-4 |
详细
|
| ICA-105574 |
化合物ICA-105574 |
316146-57-3 |
详细
|
| CBL0137 |
1,1'-(9-(2-(异丙基氨基)乙基)-9H-咔唑-3,6-二基)双乙烷-1-酮 |
1197996-80-7 |
详细
|
| Takinib |
1111556-37-6 |
1111556-37-6 |
详细
|
| HS-1793 |
化合物HS-1793 |
927885-00-5 |
详细
|
| SU5204 |
su5204 |
186611-11-0 |
详细
|
| MRT68921 HCl |
2080306-21-2 |
2080306-21-2 |
详细
|
| Enzastaurin (LY317615) |
恩扎妥林 |
170364-57-5 |
详细
|
| Sotrastaurin |
3-(1H-吲哚-3-基)-4-[2-(4-甲基哌嗪-1-基)喹唑啉-4-基]吡咯-2,5-二酮 |
425637-18-9 |
详细
|
| Thiazovivin |
THIAZOVIVIN |
1226056-71-8 |
详细
|
| INK-128 |
3-(2-氨基-5-苯并恶唑基)-1-(1-甲基乙基)-1H-吡唑并[3,4-D]嘧啶-4-胺 |
1224844-38-5 |
详细
|
| A-443654 |
(ALPHAS)-ALPHA-[[[5-(3-甲基-1H-吲唑-5-基)-3-吡啶基]氧基]甲基]-(S)-1H-吲哚-3-乙胺 |
552325-16-3 |
详细
|
| IKK-16 (IKK Inhibitor VII) |
IKK-16 |
873225-46-8 |
详细
|
| WZ 4003 |
WZ4003 |
1214265-58-3 |
详细
|
| GSK106 hydrochloride |
GSK106 (hydrochloride) |
1652591-82-6 |
详细
|
| ML385 |
ML385 |
846557-71-9 |
详细
|
| WM 1119 |
化合物WM-1119 |
2055397-28-7 |
详细
|
| LY-2940094 |
BTRX-246040 |
1307245-86-8 |
详细
|